| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 11 | 0.943 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.873 | |
| protein insertion into mitochondrial membrane | GO:0051204 | 4 | 0.802 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.797 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.552 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.545 | |
| regulation of pigment cell differentiation | GO:0050932 | 7 | 0.498 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.492 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.451 | |
| spermatogenesis | GO:0007283 | 284 | 0.410 | |
| mitochondrial outer membrane permeabilization | GO:0097345 | 10 | 0.398 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.388 | |
| regulation of mitochondrial membrane potential | GO:0051881 | 17 | 0.364 | |
| fertilization | GO:0009566 | 127 | 0.363 | |
| mitochondrial fusion | GO:0008053 | 9 | 0.361 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.360 | |
| establishment of protein localization to mitochondrion | GO:0072655 | 11 | 0.356 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.354 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.346 | |
| regulation of melanocyte differentiation | GO:0045634 | 7 | 0.345 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.343 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.335 | |
| positive regulation of mitochondrion organization | GO:0010822 | 17 | 0.320 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.319 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.298 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.296 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.294 | |
| positive regulation of mitochondrial membrane permeability | GO:0035794 | 12 | 0.283 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.283 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.277 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.270 | |
| negative regulation of retinal cell programmed cell death | GO:0046671 | 2 | 0.268 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.263 | |
| organelle fusion | GO:0048284 | 28 | 0.261 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.259 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.259 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.258 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 17 | 0.257 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.256 | Human |
| germ cell development | GO:0007281 | 185 | 0.256 | |
| dephosphorylation | GO:0016311 | 129 | 0.254 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.254 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.251 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.248 | |
| positive regulation of skeletal muscle fiber development | GO:0048743 | 3 | 0.236 | |
| spermatid differentiation | GO:0048515 | 115 | 0.235 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.235 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.235 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.233 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.233 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.229 | |
| regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902108 | 14 | 0.229 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.229 | |
| regulation of ion transport | GO:0043269 | 215 | 0.229 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.227 | Human |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.225 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.225 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.223 | |
| vesicle organization | GO:0016050 | 60 | 0.223 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.221 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.220 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.219 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.217 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.217 | Human |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.217 | |
| response to radiation | GO:0009314 | 165 | 0.216 | |
| amine metabolic process | GO:0009308 | 45 | 0.216 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.215 | |
| cellular response to starvation | GO:0009267 | 57 | 0.215 | Human |
| gtp metabolic process | GO:0046039 | 144 | 0.214 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.212 | |
| calcium ion transport | GO:0006816 | 159 | 0.208 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.208 | |
| t cell homeostatic proliferation | GO:0001777 | 4 | 0.207 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.207 | |
| membrane fusion | GO:0061025 | 38 | 0.206 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.205 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.205 | |
| urogenital system development | GO:0001655 | 261 | 0.204 | |
| cation transport | GO:0006812 | 399 | 0.203 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.203 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.202 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.202 | |
| protein localization to membrane | GO:0072657 | 108 | 0.201 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.200 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.199 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.198 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.195 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.194 | |
| mitochondrial transport | GO:0006839 | 36 | 0.194 | |
| cochlear nucleus development | GO:0021747 | 4 | 0.192 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.190 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.189 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.189 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.188 | |
| negative regulation of b cell apoptotic process | GO:0002903 | 7 | 0.188 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.187 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.187 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.186 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.186 | |
| necrotic cell death | GO:0070265 | 30 | 0.184 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.184 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.184 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.183 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.183 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.183 | |
| negative regulation of calcium ion transport into cytosol | GO:0010523 | 2 | 0.182 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.181 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.181 | |
| response to amino acid | GO:0043200 | 37 | 0.181 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.180 | |
| regulation of mammary gland involution | GO:1903519 | 4 | 0.180 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.180 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.180 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.180 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.180 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.179 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.179 | |
| regulation of neuron death | GO:1901214 | 134 | 0.177 | |
| mitochondrion organization | GO:0007005 | 134 | 0.177 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.176 | Human |
| female gonad development | GO:0008585 | 71 | 0.175 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.175 | |
| gtp catabolic process | GO:0006184 | 143 | 0.175 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.173 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.172 | |
| zymogen activation | GO:0031638 | 41 | 0.172 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.170 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.170 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.169 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.169 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.169 | |
| cell aging | GO:0007569 | 35 | 0.167 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.167 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.166 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.166 | Human |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.166 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.164 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.164 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.162 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.162 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.161 | Human |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.160 | |
| cation homeostasis | GO:0055080 | 212 | 0.160 | |
| t cell homeostasis | GO:0043029 | 35 | 0.160 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.160 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c | GO:0008635 | 4 | 0.160 | |
| renal system process | GO:0003014 | 48 | 0.159 | |
| cellular response to light stimulus | GO:0071482 | 19 | 0.158 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.158 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.157 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.157 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001267 | 4 | 0.156 | |
| cell adhesion | GO:0007155 | 329 | 0.156 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.156 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.154 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.154 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.152 | |
| kidney development | GO:0001822 | 213 | 0.152 | |
| cerebral cortex development | GO:0021987 | 86 | 0.151 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.151 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.151 | |
| ovarian follicle development | GO:0001541 | 40 | 0.151 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.147 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.147 | |
| forebrain development | GO:0030900 | 302 | 0.146 | |
| actin filament organization | GO:0007015 | 113 | 0.146 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.145 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.144 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.143 | |
| response to light stimulus | GO:0009416 | 135 | 0.143 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.143 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.143 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.142 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.142 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.141 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.141 | |
| protein oligomerization | GO:0051259 | 67 | 0.140 | Human |
| response to osmotic stress | GO:0006970 | 21 | 0.140 | |
| muscle cell development | GO:0055001 | 133 | 0.140 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.139 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.138 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.138 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.137 | |
| pigment metabolic process | GO:0042440 | 32 | 0.137 | |
| viral process | GO:0016032 | 41 | 0.136 | |
| metencephalon development | GO:0022037 | 89 | 0.135 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.135 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.135 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.135 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.135 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.135 | |
| membrane organization | GO:0061024 | 245 | 0.135 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.134 | |
| regulation of cell motility | GO:2000145 | 236 | 0.134 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.132 | |
| cellular homeostasis | GO:0019725 | 240 | 0.132 | |
| limb development | GO:0060173 | 166 | 0.132 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.132 | |
| cell junction organization | GO:0034330 | 77 | 0.131 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.131 | |
| odontogenesis | GO:0042476 | 78 | 0.131 | |
| renal system development | GO:0072001 | 225 | 0.130 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.129 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.129 | |
| regulation of b cell apoptotic process | GO:0002902 | 13 | 0.129 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.128 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.128 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.128 | |
| pigment cell differentiation | GO:0050931 | 27 | 0.127 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.127 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.127 | |
| negative regulation of endoplasmic reticulum calcium ion concentration | GO:0032471 | 3 | 0.126 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.126 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.126 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.125 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.125 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.124 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.124 | |
| viral genome replication | GO:0019079 | 17 | 0.124 | |
| response to gamma radiation | GO:0010332 | 22 | 0.124 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.123 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.123 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.123 | Human |
| adherens junction assembly | GO:0034333 | 22 | 0.123 | |
| response to acid chemical | GO:0001101 | 111 | 0.122 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001269 | 3 | 0.121 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.121 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.121 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.121 | |
| regulation of developmental pigmentation | GO:0048070 | 14 | 0.121 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.120 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.119 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.119 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.119 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.118 | |
| b cell apoptotic process | GO:0001783 | 19 | 0.118 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.117 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.117 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.117 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.116 | |
| stem cell differentiation | GO:0048863 | 268 | 0.116 | |
| activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:0097296 | 2 | 0.116 | |
| ectopic germ cell programmed cell death | GO:0035234 | 9 | 0.114 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.114 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.114 | Human |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.114 | |
| rhythmic process | GO:0048511 | 174 | 0.114 | |
| organ growth | GO:0035265 | 117 | 0.113 | |
| b cell differentiation | GO:0030183 | 78 | 0.113 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.113 | |
| endoplasmic reticulum calcium ion homeostasis | GO:0032469 | 11 | 0.113 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.112 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.111 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.111 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.111 | |
| negative regulation of growth | GO:0045926 | 99 | 0.110 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.110 | |
| nuclear division | GO:0000280 | 158 | 0.109 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.108 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.108 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.107 | |
| ureteric bud development | GO:0001657 | 94 | 0.106 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.106 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.105 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.105 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.104 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.104 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.104 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.102 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.101 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.101 | |
| limb morphogenesis | GO:0035108 | 149 | 0.101 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.101 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.100 | |
| mesonephros development | GO:0001823 | 97 | 0.100 | |
| t cell proliferation | GO:0042098 | 120 | 0.099 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.099 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.099 | |
| ear development | GO:0043583 | 200 | 0.099 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.098 | |
| b cell proliferation | GO:0042100 | 53 | 0.098 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.097 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.097 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.097 | |
| b cell homeostasis | GO:0001782 | 34 | 0.096 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.096 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.096 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.096 | |
| positive regulation of muscle tissue development | GO:1901863 | 32 | 0.095 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.094 | |
| striated muscle cell development | GO:0055002 | 125 | 0.094 | |
| protein maturation | GO:0051604 | 176 | 0.093 | |
| programmed necrotic cell death | GO:0097300 | 28 | 0.093 | |
| organelle fission | GO:0048285 | 170 | 0.093 | |
| muscle fiber development | GO:0048747 | 76 | 0.093 | |
| pallium development | GO:0021543 | 120 | 0.093 | |
| negative regulation of lymphocyte apoptotic process | GO:0070229 | 24 | 0.093 | |
| cell division | GO:0051301 | 120 | 0.092 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.092 | |
| nephron tubule development | GO:0072080 | 84 | 0.092 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.091 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.091 | |
| positive regulation of cell maturation | GO:1903431 | 4 | 0.091 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.091 | |
| myotube differentiation | GO:0014902 | 105 | 0.091 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.090 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.090 | |
| mesenchyme development | GO:0060485 | 152 | 0.090 | |
| cellular pigmentation | GO:0033059 | 20 | 0.090 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.090 | |
| female sex differentiation | GO:0046660 | 84 | 0.089 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.089 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.089 | |
| ossification | GO:0001503 | 216 | 0.089 | |
| cell fate commitment | GO:0045165 | 210 | 0.089 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.088 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.088 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.088 | |
| melanocyte differentiation | GO:0030318 | 25 | 0.088 | |
| protein localization to organelle | GO:0033365 | 185 | 0.088 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.088 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.087 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.087 | Human |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.087 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.087 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.087 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.086 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.086 | |
| cell cell junction organization | GO:0045216 | 72 | 0.086 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.086 | |
| negative regulation of nuclear division | GO:0051784 | 19 | 0.086 | |
| hindbrain development | GO:0030902 | 128 | 0.085 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.084 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.084 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.084 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.084 | |
| fear response | GO:0042596 | 33 | 0.084 | |
| viral life cycle | GO:0019058 | 36 | 0.084 | |
| positive regulation of pigment cell differentiation | GO:0050942 | 5 | 0.083 | |
| positive regulation of calcium ion transport into cytosol | GO:0010524 | 9 | 0.083 | |
| pigmentation | GO:0043473 | 71 | 0.083 | |
| male gamete generation | GO:0048232 | 285 | 0.083 | |
| metanephros development | GO:0001656 | 79 | 0.083 | |
| myeloid cell apoptotic process | GO:0033028 | 22 | 0.083 | |
| ovulation cycle | GO:0042698 | 59 | 0.082 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.082 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.082 | |
| kidney epithelium development | GO:0072073 | 121 | 0.082 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.081 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.081 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.081 | |
| response to oxygen levels | GO:0070482 | 62 | 0.081 | Human |
| cell junction assembly | GO:0034329 | 52 | 0.081 | |
| male sex differentiation | GO:0046661 | 109 | 0.080 | |
| skin development | GO:0043588 | 220 | 0.079 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.079 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.079 | |
| maintenance of location | GO:0051235 | 89 | 0.079 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.078 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.078 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.078 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.077 | |
| mammary gland involution | GO:0060056 | 9 | 0.077 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.077 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.077 | |
| muscle tissue development | GO:0060537 | 308 | 0.077 | |
| developmental pigmentation | GO:0048066 | 40 | 0.077 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.076 | |
| t cell activation | GO:0042110 | 289 | 0.076 | |
| secondary metabolic process | GO:0019748 | 18 | 0.076 | |
| positive regulation of peptidyl serine phosphorylation | GO:0033138 | 25 | 0.076 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.076 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.076 | |
| cellular response to radiation | GO:0071478 | 28 | 0.076 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.075 | |
| response to steroid hormone | GO:0048545 | 56 | 0.075 | |
| hair cycle | GO:0042633 | 90 | 0.075 | |
| axonogenesis | GO:0007409 | 274 | 0.075 | |
| angiogenesis | GO:0001525 | 201 | 0.075 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.074 | |
| mammary gland epithelial cell proliferation | GO:0033598 | 24 | 0.074 | |
| response to alkaloid | GO:0043279 | 34 | 0.074 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.074 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.074 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.073 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.073 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.073 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.073 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.073 | |
| regulation of cell migration | GO:0030334 | 219 | 0.073 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.072 | |
| response to starvation | GO:0042594 | 65 | 0.072 | Human |
| negative regulation of cell motility | GO:2000146 | 61 | 0.071 | |
| regulation of protein localization | GO:0032880 | 231 | 0.071 | |
| positive regulation of neuron maturation | GO:0014042 | 2 | 0.071 | |
| nephron development | GO:0072006 | 109 | 0.071 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.071 | |
| gonad development | GO:0008406 | 141 | 0.071 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.071 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.071 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.071 | |
| hypothalamus development | GO:0021854 | 16 | 0.071 | |
| positive regulation of b cell apoptotic process | GO:0002904 | 4 | 0.070 | |
| diencephalon development | GO:0021536 | 63 | 0.070 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.070 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.070 | |
| male gonad development | GO:0008584 | 88 | 0.069 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.069 | |
| positive regulation of cellular response to oxidative stress | GO:1900409 | 6 | 0.069 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.068 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.068 | |
| renal tubule development | GO:0061326 | 87 | 0.068 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 40 | 0.068 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.068 | |
| nephron epithelium development | GO:0072009 | 92 | 0.068 | |
| b cell activation | GO:0042113 | 161 | 0.068 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.067 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.067 | |
| regulation of ossification | GO:0030278 | 112 | 0.067 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.066 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.066 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.066 | |
| cellular response to oxygen levels | GO:0071453 | 20 | 0.066 | Human |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.066 | |
| behavioral fear response | GO:0001662 | 28 | 0.066 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.066 | |
| cell growth | GO:0016049 | 130 | 0.065 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.065 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.065 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.065 | |
| oocyte development | GO:0048599 | 33 | 0.065 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.064 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.064 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.064 | |
| protein homooligomerization | GO:0051260 | 43 | 0.064 | |
| limbic system development | GO:0021761 | 72 | 0.063 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.063 | |
| gland development | GO:0048732 | 330 | 0.063 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.063 | |
| regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway | GO:1903376 | 3 | 0.063 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.063 | Human |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.063 | |
| positive regulation of leukocyte apoptotic process | GO:2000108 | 21 | 0.063 | |
| positive regulation of neuroepithelial cell differentiation | GO:1902913 | 5 | 0.062 | |
| positive regulation of response to oxidative stress | GO:1902884 | 6 | 0.062 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.062 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.062 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.061 | |
| homeostasis of number of cells within a tissue | GO:0048873 | 25 | 0.061 | |
| myotube cell development | GO:0014904 | 60 | 0.061 | |
| neural nucleus development | GO:0048857 | 22 | 0.061 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.061 | |
| digestive tract development | GO:0048565 | 190 | 0.060 | |
| epidermis development | GO:0008544 | 187 | 0.060 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.060 | |
| negative regulation of intracellular transport | GO:0032387 | 38 | 0.059 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.059 | |
| telencephalon development | GO:0021537 | 186 | 0.059 | |
| cd8 positive alpha beta t cell lineage commitment | GO:0043375 | 1 | 0.058 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.058 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.057 | |
| camera type eye development | GO:0043010 | 266 | 0.057 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.057 | |
| neuron migration | GO:0001764 | 122 | 0.057 | |
| appendage development | GO:0048736 | 166 | 0.056 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.056 | |
| regulation of cell growth | GO:0001558 | 91 | 0.056 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.056 | |
| positive regulation of melanocyte differentiation | GO:0045636 | 5 | 0.056 | |
| positive regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway | GO:1903378 | 3 | 0.056 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.056 | |
| regulation of cell division | GO:0051302 | 76 | 0.055 | |
| tissue remodeling | GO:0048771 | 102 | 0.055 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.055 | |
| regulation of osteoblast proliferation | GO:0033688 | 15 | 0.054 | |
| negative regulation of fibroblast proliferation | GO:0048147 | 14 | 0.054 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.054 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.054 | |
| cell maturation | GO:0048469 | 127 | 0.053 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.053 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.053 | |
| apoptotic process in bone marrow | GO:0071839 | 1 | 0.053 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.053 | |
| apoptotic process involved in embryonic digit morphogenesis | GO:1902263 | 3 | 0.053 | |
| oocyte differentiation | GO:0009994 | 35 | 0.053 | |
| smooth muscle cell migration | GO:0014909 | 10 | 0.052 | |
| post embryonic organ morphogenesis | GO:0048563 | 8 | 0.052 | |
| glomerulus development | GO:0032835 | 40 | 0.052 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.052 | |
| osteoblast proliferation | GO:0033687 | 18 | 0.051 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.051 | |
| tissue homeostasis | GO:0001894 | 115 | 0.051 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.051 | |
| developmental maturation | GO:0021700 | 193 | 0.051 | |
| response to drug | GO:0042493 | 75 | 0.050 | |
| molting cycle | GO:0042303 | 90 | 0.050 | |
| protein processing | GO:0016485 | 163 | 0.050 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.048 | |
| positive t cell selection | GO:0043368 | 23 | 0.048 | |
